S
Sergio Pecorelli
Researcher at University of Brescia
Publications - 314
Citations - 28079
Sergio Pecorelli is an academic researcher from University of Brescia. The author has contributed to research in topics: Cancer & Ovarian cancer. The author has an hindex of 74, co-authored 311 publications receiving 25853 citations. Previous affiliations of Sergio Pecorelli include University of California, Irvine & University of Milan.
Papers
More filters
Journal ArticleDOI
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote,Claes G. Tropé,Frédéric Amant,G.B. Kristensen,Tom Ehlen,N Johnson,René H.M. Verheijen,Maria E. L. van der Burg,A. J. Lacave,Pierluigi Benedetti Panici,Gemma G. Kenter,Antonio Casado,Cesar Mendiola,Corneel Coens,Leen Verleye,Gavin Stuart,Sergio Pecorelli,Nicholas Reed +17 more
TL;DR: Neoadjuvant chemotherapy followed by interval debulking surgery was not inferior to primary debulked surgery followed by chemotherapy as a treatment option for patients with bulky stage IIIC or IV ovarian carcinoma in this study.
Journal ArticleDOI
Carcinoma of the Ovary.
A. P M Heintz,Franco Odicino,Patrick Maisonneuve,Michael A. Quinn,J. L. Benedet,William T. Creasman,Hys Ngan,Sergio Pecorelli,U. Beller +8 more
TL;DR: The final histologic findings after surgery (and cytologic ones when available) are to be considered in the staging, which may be modified by histopathologic as well as clinical or radiological evaluation.
Journal ArticleDOI
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.
Journal ArticleDOI
Randomized Intergroup Trial of Cisplatin–Paclitaxel Versus Cisplatin–Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
Martine Piccart,Kamma Bertelsen,Keith James,Jim Cassidy,Constantino Mangioni,Ernst Simonsen,Gavin Stuart,Stan B. Kaye,Ignace Vergote,René Blom,R. Grimshaw,Ronald J. Atkinson,Ken D. Swenerton,Claes G. Tropé,M. Nardi,Janne Kærn,Salvatore Tumolo,Petra Timmers,Josee Anne Roy,François Lhoas,Berit Lindvall,Monica Bacon,Angelo Birt,Joern Erik Andersen,Benny Zee,James Paul,Benoit Baron,Sergio Pecorelli +27 more
TL;DR: There is strong and confirmatory evidence from two large randomized phase III trials to support paclitaxel-cisplatin as the new standard regimen for treatment of patients with advanced ovarian cancer.